FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2973142183> ?p ?o ?g. }

• W2973142183 endingPage "171" @default.
• W2973142183 startingPage "159" @default.
• W2973142183 abstract "This study assessed the efficacy and safety of the anti-CD40 monoclonal antibody bleselumab (ASKP1240) in de novo kidney transplant recipients over 36 months posttransplant. Transplant recipients were randomized (1:1:1) to standard of care (SoC: 0.1 mg/kg per day immediate-release tacrolimus [IR-TAC]; target minimum blood concentration [Ctrough ] 4-11 ng/mL plus 1 g mycophenolate mofetil [MMF] twice daily) or bleselumab (200 mg on days 0/7/14/28/42/56/70/90, and monthly thereafter) plus either MMF or IR-TAC (0.1 mg/kg per day; target Ctrough 4-11 ng/mL days 0-30, then 2-5 ng/mL). All received basiliximab induction (20 mg pretransplant and on days 3-5 posttransplant) and corticosteroids. One hundred thirty-eight transplant recipients received ≥1 dose of study drug (SoC [n = 48]; bleselumab + MMF [n = 46]; bleselumab + IR-TAC [n = 44]). For the primary endpoint (incidence of biopsy-proven acute rejection [BPAR] at 6 months), bleselumab + IR-TAC was noninferior to SoC (difference 2.8%; 95% confidence interval [CI] -8.1% to 13.8%), and bleselumab + MMF did not demonstrate noninferiority to SoC (difference 30.7%; 95% CI 15.2%-46.2%). BPAR incidence slightly increased through month 36 in all groups, with bleselumab + IR-TAC continuing to demonstrate noninferiority to SoC. Bleselumab had a favorable benefit-risk ratio. Most treatment-emergent adverse events were as expected for kidney transplant recipients (ClinicalTrials.gov NCT01780844)." @default.
• W2973142183 created "2019-09-19" @default.
• W2973142183 creator A5018226716 @default.
• W2973142183 creator A5027153826 @default.
• W2973142183 creator A5039318967 @default.
• W2973142183 creator A5056026206 @default.
• W2973142183 creator A5058625232 @default.
• W2973142183 creator A5061721392 @default.
• W2973142183 creator A5072160860 @default.
• W2973142183 creator A5072787193 @default.
• W2973142183 creator A5073323112 @default.
• W2973142183 creator A5091280061 @default.
• W2973142183 date "2019-10-19" @default.
• W2973142183 modified "2023-10-14" @default.
• W2973142183 title "Efficacy and safety of bleselumab in kidney transplant recipients: A phase 2, randomized, open‐label, noninferiority study" @default.
• W2973142183 cites W1528086703 @default.
• W2973142183 cites W1528492996 @default.
• W2973142183 cites W1585519602 @default.
• W2973142183 cites W1899618550 @default.
• W2973142183 cites W1990827591 @default.
• W2973142183 cites W2002905931 @default.
• W2973142183 cites W2017390384 @default.
• W2973142183 cites W2025631961 @default.
• W2973142183 cites W2076843879 @default.
• W2973142183 cites W2077666019 @default.
• W2973142183 cites W2098974193 @default.
• W2973142183 cites W2114974207 @default.
• W2973142183 cites W2158016855 @default.
• W2973142183 cites W2165667470 @default.
• W2973142183 cites W2281213207 @default.
• W2973142183 cites W2315894134 @default.
• W2973142183 cites W2510762251 @default.
• W2973142183 cites W2586198488 @default.
• W2973142183 cites W2617234041 @default.
• W2973142183 cites W2783888490 @default.
• W2973142183 doi "https://doi.org/10.1111/ajt.15591" @default.
• W2973142183 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31509331" @default.
• W2973142183 hasPublicationYear "2019" @default.
• W2973142183 type Work @default.
• W2973142183 sameAs 2973142183 @default.
• W2973142183 citedByCount "37" @default.
• W2973142183 countsByYear W29731421832018 @default.
• W2973142183 countsByYear W29731421832019 @default.
• W2973142183 countsByYear W29731421832020 @default.
• W2973142183 countsByYear W29731421832021 @default.
• W2973142183 countsByYear W29731421832022 @default.
• W2973142183 countsByYear W29731421832023 @default.
• W2973142183 crossrefType "journal-article" @default.
• W2973142183 hasAuthorship W2973142183A5018226716 @default.
• W2973142183 hasAuthorship W2973142183A5027153826 @default.
• W2973142183 hasAuthorship W2973142183A5039318967 @default.
• W2973142183 hasAuthorship W2973142183A5056026206 @default.
• W2973142183 hasAuthorship W2973142183A5058625232 @default.
• W2973142183 hasAuthorship W2973142183A5061721392 @default.
• W2973142183 hasAuthorship W2973142183A5072160860 @default.
• W2973142183 hasAuthorship W2973142183A5072787193 @default.
• W2973142183 hasAuthorship W2973142183A5073323112 @default.
• W2973142183 hasAuthorship W2973142183A5091280061 @default.
• W2973142183 hasBestOaLocation W29731421831 @default.
• W2973142183 hasConcept C126322002 @default.
• W2973142183 hasConcept C126894567 @default.
• W2973142183 hasConcept C168563851 @default.
• W2973142183 hasConcept C197934379 @default.
• W2973142183 hasConcept C203092338 @default.
• W2973142183 hasConcept C2780303639 @default.
• W2973142183 hasConcept C2781307858 @default.
• W2973142183 hasConcept C2909675724 @default.
• W2973142183 hasConcept C2911091166 @default.
• W2973142183 hasConcept C44249647 @default.
• W2973142183 hasConcept C71924100 @default.
• W2973142183 hasConceptScore W2973142183C126322002 @default.
• W2973142183 hasConceptScore W2973142183C126894567 @default.
• W2973142183 hasConceptScore W2973142183C168563851 @default.
• W2973142183 hasConceptScore W2973142183C197934379 @default.
• W2973142183 hasConceptScore W2973142183C203092338 @default.
• W2973142183 hasConceptScore W2973142183C2780303639 @default.
• W2973142183 hasConceptScore W2973142183C2781307858 @default.
• W2973142183 hasConceptScore W2973142183C2909675724 @default.
• W2973142183 hasConceptScore W2973142183C2911091166 @default.
• W2973142183 hasConceptScore W2973142183C44249647 @default.
• W2973142183 hasConceptScore W2973142183C71924100 @default.
• W2973142183 hasIssue "1" @default.
• W2973142183 hasLocation W29731421831 @default.
• W2973142183 hasLocation W29731421832 @default.
• W2973142183 hasOpenAccess W2973142183 @default.
• W2973142183 hasPrimaryLocation W29731421831 @default.
• W2973142183 hasRelatedWork W1965287622 @default.
• W2973142183 hasRelatedWork W2101302191 @default.
• W2973142183 hasRelatedWork W2208852829 @default.
• W2973142183 hasRelatedWork W2400889191 @default.
• W2973142183 hasRelatedWork W2540384661 @default.
• W2973142183 hasRelatedWork W2583560766 @default.
• W2973142183 hasRelatedWork W2808688831 @default.
• W2973142183 hasRelatedWork W3026550437 @default.
• W2973142183 hasRelatedWork W3031156917 @default.
• W2973142183 hasRelatedWork W3166834472 @default.
• W2973142183 hasVolume "20" @default.
• W2973142183 isParatext "false" @default.

• next